CME Group Inc. $CME Shares Bought by Opal Wealth Advisors LLC

Opal Wealth Advisors LLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 55.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 921 shares of the financial services provider’s stock after acquiring an additional 328 shares during the quarter. Opal Wealth Advisors LLC’s holdings in CME Group were worth $254,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the stock. Golden State Equity Partners lifted its holdings in CME Group by 10.1% in the second quarter. Golden State Equity Partners now owns 3,897 shares of the financial services provider’s stock worth $1,074,000 after purchasing an additional 359 shares during the period. Lederer & Associates Investment Counsel CA lifted its holdings in CME Group by 2.7% in the second quarter. Lederer & Associates Investment Counsel CA now owns 4,239 shares of the financial services provider’s stock worth $1,168,000 after purchasing an additional 110 shares during the period. Arlington Partners LLC acquired a new stake in CME Group in the second quarter worth about $2,175,000. Caitlin John LLC acquired a new stake in CME Group in the second quarter worth about $1,415,000. Finally, GAMMA Investing LLC lifted its holdings in CME Group by 18.4% in the second quarter. GAMMA Investing LLC now owns 8,297 shares of the financial services provider’s stock worth $2,287,000 after purchasing an additional 1,290 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on CME shares. UBS Group reduced their price objective on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a report on Monday, September 8th. Barclays set a $298.00 price objective on shares of CME Group and gave the company an “equal weight” rating in a research report on Thursday, July 24th. Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Oppenheimer raised their price objective on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Finally, Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Four investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $260.60.

CME Group Trading Up 0.3%

Shares of CME stock opened at $261.96 on Wednesday. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business’s 50 day moving average is $271.40 and its two-hundred day moving average is $270.80. The company has a market cap of $94.41 billion, a PE ratio of 25.36, a price-to-earnings-growth ratio of 4.73 and a beta of 0.43.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the company posted $2.56 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. Equities analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is 48.40%.

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock worth $3,527,956 over the last 90 days. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.